Literature DB >> 24448672

Establishment of a rat model for canine necrotizing meningoencephalitis (NME).

E-S Park1, K Uchida2, H Nakayama1.   

Abstract

The pathogenesis of necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME) is still uncertain, although they are considered immune-mediated diseases. The purpose of the present study is to generate a rodent model(s) of these diseases. Rats were injected with rat cerebral or cerebellar homogenate. Rats injected with cerebral homogenate (Cbr) exhibited vacuolar or malacic changes mainly in the cerebral cortex. CD3-positive T cells and Iba-1-positive and CD163-negative microglia infiltrated and activated around the lesions. IgG deposited in the glial fibrillary acid protein (GFAP)-positive glia limitans from the early phase, and CD3-positive T cells attached to GFAP-positive astrocytes. Autoantibodies against GFAP were detected in the sera. These pathological features of Cbr rats were consistent with those of canine NME. In contrast, rats injected with cerebral homogenate (Cbe) exhibited demyelinating lesions with inflammatory reactions in the cerebellum, brainstem, and spinal cord. The presence of demyelination and autoantibodies against myelin proteins in Cbe rats was similar to murine experimental autoimmune encephalitis and differed from NME, NLE, and GME. All the present findings indicate that autoantibodies together with microglia and T cells may play a major role in the pathogenesis of idiopathic canine meningoencephalomyelitis.
© The Author(s) 2014.

Entities:  

Keywords:  animal model; autoantibody; dog; experimental autoimmune encephalitis (EAE); necrotizing meningoencephalitis (NME)

Mesh:

Substances:

Year:  2014        PMID: 24448672     DOI: 10.1177/0300985813519115

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

Review 1.  Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.

Authors:  Fulan Shan; Youming Long; Wei Qiu
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 7.561

2.  Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies.

Authors:  Jonathan Wickel; Ha-Yeun Chung; Klaus Kirchhof; David Boeckler; Stefan Merkelbach; Peter Kuzman; Wolf C Mueller; Christian Geis; Albrecht Günther
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-02-04

3.  Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.

Authors:  Joong-Hyun Song; Do-Hyeon Yu; Tae-Sung Hwang; Byung-Joon Seung; Jung-Hyang Sur; Young Joo Kim; Dong-In Jung
Journal:  Vet Med Sci       Date:  2020-06-25

4.  Serological biomarkers in autoimmune GFAP astrocytopathy.

Authors:  Cong-Cong Fu; Lu Huang; Lu-Fen Xu; Li-Hong Jiang; Hui-Lu Li; Sha Liao; Jiajia Yue; Chun Lian; Xin-Guang Yang; You-Ming Long
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

5.  Concomitant necrotizing encephalitis and granulomatous meningoencephalitis in four toy breed dogs.

Authors:  Jasmin Nicole Nessler; Anna Oevermann; Marina Schawacht; Ingo Gerhauser; Ingo Spitzbarth; Sophie Bittermann; Frank Steffen; Martin Jürgen Schmidt; Andrea Tipold
Journal:  Front Vet Sci       Date:  2022-09-01

6.  International veterinary epilepsy task force recommendations for systematic sampling and processing of brains from epileptic dogs and cats.

Authors:  Kaspar Matiasek; Martí Pumarola I Batlle; Marco Rosati; Francisco Fernández-Flores; Andrea Fischer; Eva Wagner; Mette Berendt; Sofie F M Bhatti; Luisa De Risio; Robyn G Farquhar; Sam Long; Karen Muñana; Edward E Patterson; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Heidrun Potschka; Clare Rusbridge; Veronika M Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.